Smith & Nephew SNATS, Inc. (SNN) Shares Bought by Bbva Compass Bancshares Inc.

Bbva Compass Bancshares Inc. raised its position in Smith & Nephew SNATS, Inc. (NYSE:SNN) by 13.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 46,008 shares of the medical equipment provider’s stock after buying an additional 5,275 shares during the period. Bbva Compass Bancshares Inc.’s holdings in Smith & Nephew SNATS were worth $1,603,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in SNN. Dalton Greiner Hartman Maher & Co. increased its position in shares of Smith & Nephew SNATS by 2,645.8% in the second quarter. Dalton Greiner Hartman Maher & Co. now owns 497,676 shares of the medical equipment provider’s stock worth $17,344,000 after buying an additional 479,551 shares during the period. Citadel Advisors LLC increased its position in shares of Smith & Nephew SNATS by 456.2% in the first quarter. Citadel Advisors LLC now owns 405,596 shares of the medical equipment provider’s stock worth $12,545,000 after buying an additional 332,669 shares during the period. Karp Capital Management Corp acquired a new position in shares of Smith & Nephew SNATS during the first quarter worth $10,007,000. Cambiar Investors LLC increased its position in shares of Smith & Nephew SNATS by 6.2% in the first quarter. Cambiar Investors LLC now owns 5,143,756 shares of the medical equipment provider’s stock worth $159,096,000 after buying an additional 301,213 shares during the period. Finally, Bank of America Corp DE increased its position in shares of Smith & Nephew SNATS by 10.9% in the first quarter. Bank of America Corp DE now owns 1,526,036 shares of the medical equipment provider’s stock worth $47,200,000 after buying an additional 149,672 shares during the period. 7.23% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Smith & Nephew SNATS, Inc. (NYSE:SNN) traded up 0.20% during midday trading on Friday, hitting $35.06. The company had a trading volume of 338,100 shares. Smith & Nephew SNATS, Inc. has a 12-month low of $26.97 and a 12-month high of $35.85. The company’s 50-day moving average price is $34.90 and its 200 day moving average price is $32.98. The company has a market capitalization of $15.35 billion, a price-to-earnings ratio of 17.85 and a beta of 0.76.

COPYRIGHT VIOLATION NOTICE: “Smith & Nephew SNATS, Inc. (SNN) Shares Bought by Bbva Compass Bancshares Inc.” was originally posted by BNB Daily and is the property of of BNB Daily. If you are viewing this piece of content on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.baseball-news-blog.com/2017/08/14/smith-nephew-snats-inc-snn-stake-increased-by-bbva-compass-bancshares-inc-updated.html.

A number of equities analysts have weighed in on SNN shares. BidaskClub downgraded Smith & Nephew SNATS from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Zacks Investment Research raised Smith & Nephew SNATS from a “hold” rating to a “buy” rating and set a $38.00 target price on the stock in a research report on Tuesday, July 11th. Four research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $38.00.

About Smith & Nephew SNATS

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Institutional Ownership by Quarter for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply